Advertisement

Topics

Latest Hepatology NewsRSS

18:22 EST 17th November 2017 | BioPortfolio

Global and Asia Metal Fencing Market Status and Future Forecast 20132023 [Report Updated: 10112017] Prices from USD $3000

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPart 3:Asia Market by company, Type, Application RegionPart 410:Key Regions of Asia Market by Type, ApplicationPart 11:Company information, Sales, Cost, Margin etc.Part 12:ConclusionMarket Segment as fo...

Proprotein Convertase Subtilisin/Kexin Type 9 Proprotein Convertase 9 or Neural Apoptosis Regulated Convertase 1 or Subtilisin/Kexin Like Protease PC9 or PCSK9 or EC 3.4.21. Pipeline Review, H2 2017 [Report Updated: 10102017] Prices from USD $3500

Proprotein Convertase Subtilisin/Kexin Type 9 Proprotein Convertase 9 or Neural Apoptosis Regulated Convertase 1 or Subtilisin/Kexin Like Protease PC9 or PCSK9 or EC 3.4.21. Pipeline Review, H2 2017SummaryProprotein Convertase Subtilisin/Kexin Type 9 Proprotein Convertase 9 or Neural Apoptosis Regulated Convertase 1 or Subtilisin/Kexin Like Protease PC9 or PCSK9 or EC 3.4.21. pipeline Target cons...

Tolvaptan reduces eGFR decline in patients with polycystic kidney disease

1. Estimated glomerular filtration rate (eGFR) declined less over one year of treatment for patients with later-stage autosomal dominant polycystic kidney disease (ADPKD) taking tolvaptan than those taking placebo. 2. Liver enzyme increases above 3 times the upper limit of normal (ULN) and serious liver-related events occurred more in the tolvaptan group than the placebo […]

Pfizer Receives FDA Approval for SUTENT® (sunitinib malate) as First and Only Adjuvant Treatment for Adult Patients at High Risk of Recurrent Renal Cell Carcinoma

Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration has approved a new indication expanding the use of SUTENT® (sunitinib malate) to include the adjuvant treatment of adult patients at high risk of recurrent renal cell carcinoma (RCC) following nephrectomy (surgical removal of the cancerous kidney). The approval was based on ...

Global Topotecan Hydrochloride Market Data List by Segment 20152022 [Report Updated: 07112017] Prices from USD $800

SnapshotTopotecan Hydrochloride is the hydrochloride salt of a semisynthetic derivative of camptothecin with antineoplastic activity. During the S phase of the cell cycle, topotecan selectively stabilizes topoisomerase IDNA covalent complexes, inhibiting religation of topoisomerase Imediated singlestrand DNA breaks and producing potentially lethal doublestrand DNA breaks when complexes are encount...

Liver Cirrhosis Epidemiology Forecast to 2025 [Report Updated: 10102017] Prices from USD $2200

DelveInsight Liver Cirrhosis Epidemiology Forecast To 2025 provides an overview of the epidemiology trends of Liver Cirrhosis in seven major markets US, France, Germany, Italy, Spain, UK and Japan. It includes 10 years epidemiology historical and forecasted data of Liver Cirrhosis prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk f...

Conatus Pharmaceuticals Inc CNAT Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

SummaryConatus Pharmaceuticals Inc Conatus is a biotechnology company that develops and commercializes novel medicines and disease and therapeutics for treating liver diseases. The company's lead pipeline candidate, emricasan is an orally active pancaspase protease inhibitor that concentrates on reducing the activity of human caspases, which are enzymes mediating apoptosis and inflammation. Its em...

From Lifestyle to Liver Cancer

The American Liver Foundation and Bayer partner again for the annual Are You At Risk? campaign. NEW YORK (PRWEB) November 15, 2017 Liver cancer is the second-leading cause of cancer-related deaths in the world.1 Liver cancer may be talked about less than other cancer types, but it claims the lives of more than 79 Americans each day, or nearly 29,000 per year.2 A video accompanying this announceme...

A ‘Google Maps’ for the Mouse Brain Details Neurons Like Never Before

Ask any neuroscientist to draw you a neuron, and it’ll probably look something like a star with two tails: one stubby with extensive tree-like branches, the other willowy, lengthy and dotted with spindly spikes. While a decent abstraction, this cartoonish image hides the uncomfortable truth that scientists still don’t know much about what many neurons […]

.Earth Domain Celebrates Second Anniversary By Making a Positive Impact Both Online and Offline

For Two-Year Anniversary, Technology Company Interlink is Giving Ultimate Gift to Earth by Helping to Reforest the Earth One Tree at a Time Tokyo (PRWEB) November 15, 2017 Interlink Co., Ltd., the official operator of the .Earth domain registry, today celebrates the two-year anniversary of the public launch of the .Earth top-level domain (TLD) by pledging to make a real-world impact by planting o...

Liver Cirrhosis Market Insights, Epidemiology and Market Forecast 2025 [Report Updated: 10102017] Prices from USD $4600

DelveInsight's Liver Cirrhosis Market Insights, Epidemiology and Market Forecast Market Insights, Epidemiology and Market Forecast 2025 report provides an overview of the disease and in depth research related to Liver Cirrhosis Market Insights, Epidemiology and Market Forecast for the 7MM United States, Germany, France, Italy, Spain and UK for the study period undertaken from 20152025.This rep...

Vaccine shortage stalls San Diego’s effort to battle hepatitis A outbreak

San Diego County is postponing inoculations against the contagious liver disease until a national shortage of the vaccine is resolved.

Global and Asia Metal Biliary Stent Market Status and Future Forecast 20132023 [Report Updated: 09112017] Prices from USD $3000

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPart 3:Asia Market by company, Type, Application RegionPart 410:Key Regions of Asia Market by Type, ApplicationPart 11:Company information, Sales, Cost, Margin etc.Part 12:ConclusionMarket Segment as fo...

Enanta Pharmaceuticals to Host Conference Call on November 20 at 4:30 p.m. ET to Discuss Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2017

Enanta Pharmaceuticals, Inc., (NASDAQ:ENTA), a chemistry-driven biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that it plans to report its financial results for its fiscal fourth quarter and year ended September 30, 2017, after the U.S. markets close on November 20, 2017. Enanta man...

JDRF launches initiative to support development of artificial pancreas technology

JDRF announced a new initiative that will support the development of open-protocol artificial pancreas technology, according to a press release from the organization.As Endocrine Today previously reported, the first commercial hybrid closed-loop insulin delivery system, sometimes referred to as an artificial pancreas, is on the market and other similar devices are being developed.While waiting for...

NADPH Oxidase 4 Kidney Oxidase 1 or KOX1 or Kidney Superoxide Producing NADPH Oxidase or Renal NADPH Oxidase or NOX4 or EC 1.6.3. Pipeline Review, H2 2017 [Report Updated: 31102017] Prices from USD $3500

NADPH Oxidase 4 Kidney Oxidase 1 or KOX1 or Kidney Superoxide Producing NADPH Oxidase or Renal NADPH Oxidase or NOX4 or EC 1.6.3. Pipeline Review, H2 2017SummaryAccording to the recently published report 'NADPH Oxidase 4 Pipeline Review, H2 2017'; NADPH Oxidase 4 Kidney Oxidase 1 or KOX1 or Kidney Superoxide Producing NADPH Oxidase or Renal NADPH Oxidase or NOX4 or EC 1.6.3. pipeline Target cons...

Global Metabolic Partnering 20102017: Deal trends, players and financials [Report Updated: 01112017] Prices from USD $2995

Global Metabolic Partnering 2010 to 2017 provides the full collection of Metabolic disease deals signed between the world's pharmaceutical and biotechnology companies since 2010. Trends in Metabolic partnering dealsFinancial deal terms for headline, upfront and royalty by stage of developmentMetabolic partnering agreement structureMetabolic partnering contract documentsTop Metabolic deals by value...

Enanta Pharmaceuticals Ranked as One of North America’s Fastest Growing Companies on Deloitte’s 2017 Technology Fast 500™

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a chemistry-driven biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced its inclusion on Deloitte’s Technology Fast 500™, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies in ...

News and press releases: EMA concludes review of Zinbryta and confirms further restrictions to reduce risk of liver damage

Zinbryta to be used in restricted patient group, with strict liver monitoring

Glucokinase Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2 Pipeline Review, H2 2017 [Report Updated: 10102017] Prices from USD $3500

Glucokinase Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2 Pipeline Review, H2 2017SummaryGlucokinase Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2 pipeline Target constitutes close to 11 molecules. Out of which approximately 9 molecules are developed by companies and remaining by the universities/institutes. The latest report Glucokinase Hexokinase D or Hexokinase 4 or GCK or EC 2.7.1.2 ...

vTv Therapeutics Initiates Phase 1b/2 Study Evaluating TTP399 for the Treatment of Type 1 Diabetes

As Part of Industry Partnership with JDRF vTv Therapeutics Inc. (Nasdaq: VTVT) announced today the initiation of simplici-T1, an adaptive Phase1b/2 study assessing the pharmacokinetics, pharmacodynamics, safety, and tolerability of TTP399 in adult patients with type 1 diabetes (T1D). The study is designed to evaluate whether TTP399 is well tolerated w...

Type 1 Diabetes Juvenile Diabetes Pipeline Review, H2 2017 [Report Updated: 07112017] Prices from USD $2500

Type 1 Diabetes Juvenile Diabetes Pipeline Review, H2 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Type 1 Diabetes Juvenile Diabetes Pipeline Review, H2 2017, provides an overview of the Type 1 Diabetes Juvenile Diabetes Metabolic Disorders pipeline landscape.Type 1 diabetes T1D is an autoimmune disease in which a pancreas stops producing insulin...

Hepcidin Liver Expressed Antimicrobial Peptide 1 or Putative Liver Tumor Regressor or HAMP Pipeline Review, H2 2017 [Report Updated: 31102017] Prices from USD $3500

Hepcidin Liver Expressed Antimicrobial Peptide 1 or Putative Liver Tumor Regressor or HAMP Pipeline Review, H2 2017SummaryAccording to the recently published report 'Hepcidin Pipeline Review, H2 2017'; Hepcidin Liver Expressed Antimicrobial Peptide 1 or Putative Liver Tumor Regressor or HAMP pipeline Target constitutes close to 5 molecules. Out of which approximately 5 molecules are developed by...

Caspase 3 Apopain or Cysteine Protease CPP32 or Protein Yama or SREBP Cleavage Activity 1 or CASP3 or EC 3.4.22.56 Pipeline Review, H2 2017 [Report Updated: 31102017] Prices from USD $3500

Caspase 3 Apopain or Cysteine Protease CPP32 or Protein Yama or SREBP Cleavage Activity 1 or CASP3 or EC 3.4.22.56 Pipeline Review, H2 2017SummaryCaspase 3 Apopain or Cysteine Protease CPP32 or Protein Yama or SREBP Cleavage Activity 1 or CASP3 or EC 3.4.22.56 pipeline Target constitutes close to 16 molecules. Out of which approximately 11 molecules are developed by companies and remaining by the...

Gallbladder Cancer Market Insights, Epidemiology and Market Forecast 2025 [Report Updated: 10102017] Prices from USD $5750

DelveInsight's Gallbladder Cancer Market Insights, Epidemiology and Market Forecast Market Insights, Epidemiology and Market Forecast 2025 report provides an overview of the disease and in depth research related to Gallbladder Cancer Market Insights, Epidemiology and Market Forecast for the 7MM United States, Germany, France, Italy, Spain and UK for the study period undertaken from 20152025.Th...

Quick Search
Advertisement
 

review and buy Hepatology market research data and corporate reports here